Significantly increased threshold dose after long-term peanut epicutaneous immunotherapy and daily oral peanut intake

Ann Allergy Asthma Immunol. 2020 Apr;124(4):403-405.e1. doi: 10.1016/j.anai.2020.01.021. Epub 2020 Feb 20.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Desensitization, Immunologic / methods*
  • Humans
  • Male
  • Peanut Hypersensitivity / prevention & control*